Drops for pupil constriction: why are they prescribed?

Miotics are eye drops that cause pupil constriction. Historically, they were widely used for glaucoma, but currently, prostaglandin analogs and selective laser trabeculoplasty are the first-line treatments for chronic open-angle glaucoma. Miotics have become niche due to side effects and limitations of use. However, new indications have emerged: reversible improvement of near vision in presbyopia and pharmacological "reversal" of pupil constriction after diagnostic dilation. [1]

A classic miotic is pilocarpine, a muscarinic agonist that contracts the pupillary sphincter and ciliary muscle, improving trabecular outflow and reducing intraocular pressure. However, the drug has significant visual "costs": accommodation spasm, difficulty seeing in twilight, risk of induced myopia, and other effects, limiting long-term use in some patients. [2]

The current line includes pilocarpine solutions for presbyopia: 1.25% pilocarpine under the trade name, as well as low-dose 0.4% pilocarpine. They improve near vision through the "aperture effect" by reducing pupil diameter. This does not "rejuvenate" the lens, but it does improve reading and close work for several hours. [3]

For pupil reconstriction following diagnostic mydriasis, the FDA approved 0.75% ophthalmic phentolamine, an alpha-adrenergic blocker that accelerates pupil reconstitution, thereby reducing photophobia and blurring. This is a convenient option in ophthalmological practice after phenylephrine or tropicamide instillation. [4]

Finally, in acute situations of primary angle closure, pilocarpine is still used as part of the protocol after initial pressure reduction, with laser peripheral iridotomy providing definitive resolution. Options differ in their mechanisms, efficacy, and safety profiles, so the choice is made on an individual basis. [5]

Table 1. Where pupil-constricting drops are appropriate in modern practice

Scenario	Target	Example of a remedy	Comment
Presbyopia in adults	Temporary improvement in near vision	Pilocarpine 1.25% or 0.4%	The effect appears within 15-20 minutes and lasts for hours.
Reversal of narrowing after diagnostic mydriasis	Return pupil size to normal faster	Phentolamine 0.75%	Start time is approximately 30 minutes, peak time is 60-90 minutes.
Acute angle closure	Adjuvant after pressure decompression	Pilocarpine	Before laser iridotomy, not the first step
Intraoperative myositis	Mechanical narrowing during surgery	Carbachol for intraocular administration	Used in the operating room
Plateau iris in selected patients	Temporary "thinning" of the iris	Various forms of pilocarpine	Individual indications

[6]

Mechanism of action and main classes

Muscarinic agonists activate the iris sphincter and ciliary muscle receptors. Pupil constriction reduces spherical aberrations, increases depth of field, and partially compensates for presbyopia. Contraction of the ciliary muscle pulls on the scleral spur, opening the trabeculae and improving aqueous humor outflow. This explains the dual benefits of pilocarpine in certain glaucoma scenarios. [7]

Pilocarpine is available in several ophthalmic formulations. For presbyopia, 1.25% and 0.4% drops are available, with differences in tolerability and duration of effect, supported by regulatory documents and reviews. For chronic pressure reduction, more concentrated forms are used less frequently due to their tolerability and safety profile. [8]

Ophthalmic alpha-adrenergic blockers, such as phentolamine, are not "classical" miotics, but functionally constrict the pupil by blocking the iris dilator and reducing the effects of adrenergic agonists, allowing for rapid reversal of diagnostic dilation. This mechanism has been confirmed in clinical pharmacology and approval protocols. [9]

Long-acting cholinesterase inhibitors such as echothiophate have historically been used as persistent miotics, but their use is limited by significant local and systemic effects and interactions, including clinically significant prolongation of the response to suxamethonium in anesthesiology.[10]

Intraocular forms of carbachol are used primarily intraoperatively for rapid and predictable myositis and to limit intraocular pressure increases in the early postoperative period. These are not household drops, but a surgical tool. [11]

Table 2. Classes of pupil constricting agents and examples

Class	Mechanism	Examples	Typical application
Muscarinic agonists	Stimulation of the sphincter pupillae and ciliary muscle	Pilocarpine 1.25% and 0.4%	Presbyopia, certain glaucoma scenarios
Alpha blockers	Iris dilator block	Phentolamine 0.75%	Reversal of pharmacological expansion
Cholinesterase inhibitors	Increased acetylcholine	Echothiophate	Rarely, due to risks and interactions
Cholinomimetics for intraoperative myositis	Direct effect on the iris	Carbachol	Ophthalmic surgery

[12]

Indications and clinical scenarios

Presbyopia. Pilocarpine 1.25% and pilocarpine 0.4% are approved for the temporary improvement of near vision in adults. The effect begins in approximately 15-20 minutes and can last for several hours. Repeated instillations are permitted throughout the day, according to the labeling. This is pharmacological compensation, not treatment of the underlying cause. [13]

Reversal of pharmacological mydriasis. Phentolamine 0.75% is a drug that accelerates pupil reversal after diagnostic dilation with phenylephrine or tropicamide. Onset of action is observed in approximately 30 minutes, with a maximum duration of 60-90 minutes. This reduces photophobia and blurring in patients after fundus examination. [14]

Acute angle closure. In an acute attack of primary angle closure, pilocarpine is used after initial reduction of intraocular pressure with hyperosmotic and other agents, as the iris may be "ischemic" and less responsive to miotics due to very high pressure. Laser peripheral iridotomy is then performed as a definitive step. [15]

Plateau iris and narrow angles. In some patients, low concentrations of pilocarpine temporarily "thin" the iris and help open the angle until surgery is considered. This approach is individualized and takes into account tolerability and risks. [16]

Intraoperative miosis. Intraocular carbachol is used to provide reliable miosis during surgery and to reduce the early rise in intraocular pressure after cataract extraction. This is a specific task for the operating room, not for outpatient eye drops. [17]

Table 3. Indications: what, when and why

Situation	Preparation	Target	Key feature
Presbyopia	Pilocarpine 1.25%, 0.4%	Improved near vision for several hours	Dosage once or twice daily as per labeling
Reversal of mydriasis	Phentolamine 0.75%	Return the pupil to normal size faster	Starts around 30 minutes, peak 60-90 minutes
Acute closed angle	Pilocarpine	Mechanically pull the iris after the pressure has been reduced	Next is laser iridotomy
Plateau Iris	Low concentration pilocarpine	Temporary stabilization before surgery	Individual solution
Operation	Carbachol intraocular	Miosis during intervention	Applied by a surgeon

[18]

Contraindications and important limitations

Miotics are contraindicated in active anterior uveitis and glaucoma associated with iridocyclitis. Pupil constriction in these conditions worsens inflammation and increases the risk of posterior synechiae. This is reiterated in both pharmacological monographs and clinical reviews. [19]

In suspected malignant glaucoma, known as aqueous misdirection syndrome, miotics may worsen anterior displacement of the iris-lens diaphragm. In this scenario, cycloplegics and other measures are indicated, and miotics are excluded. [20]

In patients with retinal risk factors, including high myopia and previous retinal tears, miotics increase the risk of retinal detachment. A fundus examination is recommended for these patients before prescribing pilocarpine. [21]

In some secondary glaucoma and inflammatory conditions, miotics reduce iris motility and impair the blood-aqueous barrier, increasing the risk of adhesions and cataracts. A specialist ophthalmologist makes the choice of therapy in these situations. [22]

General factors are also taken into account: asthma, bronchospasm, night driving, childhood, pregnancy, and lactation. Some risks are described in instructions and clinical reviews, so prescribing outside of absolute indications requires an individual assessment. [23]

Table 4. Who should not take miotics?

State	Why is this important?
Active anterior uveitis	Increased inflammation and adhesions in miosis
Malignant glaucoma	Miotics may aggravate the disease mechanism
High myopia, retinal pathologies	Risk of retinal detachment
A series of secondary glaucomas	Deterioration of iris motility and barrier function
Night driving	Increased "twilight" myopia and deterioration of vision

[24]

Safety and side effects

The most common local reactions to pilocarpine include burning upon instillation, lacrimation, "suprabrow pain," and accommodation spasm, which improves near vision and temporarily impairs distance vision. Many patients report difficulty in twilight and at night. These effects are described in the instructions and clinical literature. [25]

Rare but significant risks include retinal tears and detachment, especially in individuals with predisposing factors, as well as visual field narrowing with severe miosis. In recent years, studies have emerged on the increased risk of rhegmatogenous detachment with the use of pilocarpine in some patients with presbyopia. [26]

Systemic effects are unlikely for modern ocular formulations, but nausea, sweating, and bradycardia have been reported with significant absorption. This risk is reduced by applying pressure to the nasolacrimal duct for a minute after instillation. [27]

For ophthalmic phentolamine, the adverse event profile includes redness, mild discomfort, and transient blurring, but the agent has shown a reproducible and rapid reduction in pupil diameter after diagnostic dilation.[28]

Intraoperative carbachol has specific operating room risks and is not used at home. Its safety and indications are determined by the surgeon in the context of interventions on the lens and anterior segment. [29]

Table 5. Common and important side effects

Preparation	Frequent	Less often, but significantly	Pragmatic commentary
Pilocarpine ophthalmic	Burning, tearing, pain in the eyebrow, twilight difficulties	Retinal tears and detachments in predisposed individuals	Assessment of the retinal periphery in risk groups
Phentolamine ophthalmic	Redness, discomfort	Transient fog	Plan a post-inspection regimen
Echothiophate	Local reactions, systemic interactions	Anesthetic risks	Rare use
Carbachol intraocular	Intraoperative reactions	Increased blood pressure in the early postoperative period	Control by a surgeon

[30]

Interactions and special clinical situations

Echothiophate, when used long-term, inhibits plasma cholinesterase, which can significantly prolong the action of depolarizing muscle relaxants in anesthesiology. These interactions have been described for decades and remain clinically significant during surgical planning. [31]

In malignant glaucoma, miotics may worsen the situation, so in such cases cycloplegics and concomitant treatment are prescribed based on a modern review and recommendations of professional societies. [32]

In patients with plateau iris, miotics are sometimes used as a bridge to surgical correction, but a long-term strategy requires risk assessment, particularly for night vision and quality of life. Individualized concentration adjustment minimizes discomfort. [33]

Inflammatory diseases of the anterior segment are a contraindication to miosis. Here, agents that prevent adhesions and control inflammation are preferred, while miotics are excluded, a point repeated in clinical reviews and reference books. [34]

Concomitant conditions such as asthma and bronchospasm are taken into account, as well as the patient's daily routine, particularly the need for night driving. The instructions specifically warn of precautions in low-light conditions. [35]

Table 6. Key interactions and special cases

Situation	Risks	Tactics
Echothiophate and anesthesia	Long-term response to suxamethonium	Be sure to notify the anesthesiologist
Malignant glaucoma	Worsening with miotics	Cycloplegics and specialized therapy
Plateau Iris	Side effects with long-term use	Low concentrations as a bridge to surgery
Inflammation of the anterior segment	Growth of adhesions and inflammation	Avoid miotics
Night driving	Twilight visual difficulties	Plan the instillation regime

[36]

Dosage and practical schemes

Pilocarpine 1.25% for presbyopia: one drop in each eye once daily, with a second instillation permitted after 3-6 hours as directed by a physician. If using other eye drops, maintain an interval of at least 5 minutes. Remove contact lenses before instillation. [37]

Pilocarpine 0.4% for presbyopia: one drop in each eye, may be repeated up to twice daily at 2-3 hour intervals, depending on tolerance and the daily task. The drug is available in single-use containers, which improves convenience and sterility. [38]

Phentolamine 0.75% for reversal of diagnostic mydriasis: Use in the physician's office as directed from a single-use vial. Onset of action occurs within approximately 30 minutes, with peak effect occurring within 60-90 minutes. Adults typically require only one application. [39]

Acute attack of angle-closure: Pilocarpine is administered after initial pressure reduction and stabilization of corneal edema, as the miotic response is reduced at very high pressures. Laser peripheral iridotomy is then included in the plan. [40]

Intraoperative carbachol: Intraocular injection under surgeon's control to achieve myositis and limit early pressure rise after lens surgery. Not for outpatient use. [41]

Table 7. Typical application modes

Preparation	Mode	When they repeat	Special instructions
Pilocarpine 1.25%	1 drop in each eye once a day	If necessary, after 3-6 hours	The interval with other drops should be at least 5 minutes.
Pilocarpine 0.4%	1 drop in each eye	Up to 2 times a day with an interval of 2-3 hours	Disposable containers
Phentolamine 0.75%	As prescribed by a doctor	Usually once a day on the day of examination	The effect begins in about 30 minutes.
Pilocarpine for acute angle closure	After the pressure has dropped	According to the department protocol	Then laser iridotomy
Carbachol intraocular	In the operating room	Not applicable	The surgeon's decision

[42]

Practical advice for patients

If you're prescribed drops for presbyopia, plan your use according to your daily tasks: reading, working at a screen, and close-range meetings. Twilight vision may temporarily deteriorate, so it's best to avoid driving at night and working in low light. [43]

Remove contact lenses before instillation and maintain a safe interval between drops. This reduces the risk of irritation and ensures a predictable concentration of the drug on the ocular surface. [44]

If you experience flashes of light, a "curtain" in front of your eye, or sudden floaters, seek emergency care immediately due to the risk of retinal tear or detachment. This is especially important in cases of high myopia and known retinal changes. [45]

When you visit your doctor for pupil dilation, you can discuss the possibility of pharmacological reversal with your doctor in advance. This speeds recovery and reduces discomfort from photophobia and blurring after a fundus examination. [46]

Any systemic drops require notification of the attending physician, especially before general anesthesia and in the presence of respiratory diseases. Even rare interactions confirmed in the literature are taken into account when planning interventions. [47]

Table 8. Safe use instructions

Step	Why do this?
Remove lenses before instillation	Reduced risk of irritation and absorption disorders
Take a pause between different drops	Stable concentration of each product
Avoid driving at night after instillation.	Preventing accidents due to twilight vision difficulties
Monitor for retinal symptoms	Early detection of ruptures and detachments
Report the use of drops at appointments	Prevention of drug interactions

[48]

Frequently asked questions

Can pilocarpine be used "every day" for presbyopia? Yes, according to the label, but the regimen should be determined with a doctor, taking into account tolerance and the patient's goals. It's important to understand that the effect is temporary and depends on lighting conditions and the individual's eye characteristics. [49]

Is pilocarpine dangerous for the retina? Tears and detachments are rare, but possible in susceptible patients. In the presence of high myopia or retinal changes, a peripheral examination is helpful before starting therapy. If "lightning" or "curtain" symptoms appear, immediate medical attention is required. [50]

How quickly will dilation resolve after a doctor's examination? 0.75% phentolamine drops are available that accelerate the return of normal pupil size. The effect develops within approximately half an hour and reaches its maximum in an hour and a half. [51]

Is pilocarpine necessary for acute angle closure? Yes, but only as part of a protocol after rapid pressure reduction, followed by laser peripheral iridotomy. This decision is made by an emergency ophthalmologist. [52]

Why aren't miotics used for uveitis? Miosis increases the risk of adhesions and worsens inflammation in the anterior segment, so miotics are contraindicated in such cases. [53]

Conclusions

Pupil-constricting drops have found new niches: pharmacological treatment of presbyopia and accelerated reversal of diagnostic dilation. At the same time, they remain a tool in acute glaucoma situations and in specific anatomical scenarios. The key to safe use is strict indications, consideration of contraindications, attention to night vision and retinal risks, and adherence to dosage guidelines in official instructions. [54]